Concepts (136)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mammary Glands, Human | 1 | 2018 | 200 | 0.580 |
Why?
|
| Mammary Glands, Animal | 1 | 2018 | 277 | 0.570 |
Why?
|
| Computer Graphics | 1 | 2016 | 360 | 0.490 |
Why?
|
| Glioblastoma | 4 | 2023 | 3456 | 0.420 |
Why?
|
| Sequence Analysis, DNA | 1 | 2016 | 4801 | 0.260 |
Why?
|
| Carcinoma, Ductal, Breast | 2 | 2023 | 1101 | 0.240 |
Why?
|
| Receptors, Interleukin-1 Type I | 1 | 2023 | 30 | 0.240 |
Why?
|
| Genomics | 2 | 2019 | 5692 | 0.200 |
Why?
|
| MyoD Protein | 1 | 2021 | 151 | 0.190 |
Why?
|
| Muscle Development | 1 | 2021 | 271 | 0.170 |
Why?
|
| Cyclin-Dependent Kinase 4 | 2 | 2023 | 535 | 0.160 |
Why?
|
| Interleukin-1beta | 1 | 2023 | 972 | 0.160 |
Why?
|
| Gene Amplification | 2 | 2023 | 1062 | 0.150 |
Why?
|
| Epithelial Cells | 2 | 2021 | 3678 | 0.150 |
Why?
|
| Algorithms | 2 | 2019 | 13853 | 0.150 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p18 | 1 | 2016 | 53 | 0.150 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2021 | 890 | 0.150 |
Why?
|
| Colorectal Neoplasms | 1 | 2016 | 6754 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2017 | 417 | 0.140 |
Why?
|
| Nitrogen Mustard Compounds | 1 | 2016 | 45 | 0.140 |
Why?
|
| RNA, Neoplasm | 1 | 2019 | 768 | 0.140 |
Why?
|
| Isothiocyanates | 1 | 2016 | 51 | 0.140 |
Why?
|
| Genes, APC | 1 | 2016 | 159 | 0.140 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2023 | 947 | 0.140 |
Why?
|
| Radiation Tolerance | 1 | 2017 | 484 | 0.130 |
Why?
|
| Signal Transduction | 2 | 2019 | 23387 | 0.120 |
Why?
|
| BRCA2 Protein | 1 | 2019 | 790 | 0.120 |
Why?
|
| Tumor Microenvironment | 3 | 2023 | 3564 | 0.120 |
Why?
|
| Neoplasms | 5 | 2023 | 21596 | 0.120 |
Why?
|
| Cell Lineage | 2 | 2023 | 2504 | 0.120 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2016 | 704 | 0.110 |
Why?
|
| Sequence Analysis, RNA | 2 | 2018 | 2011 | 0.110 |
Why?
|
| Histones | 1 | 2023 | 2597 | 0.110 |
Why?
|
| BRCA1 Protein | 1 | 2019 | 1145 | 0.110 |
Why?
|
| Mutation, Missense | 1 | 2022 | 2556 | 0.110 |
Why?
|
| Mouth Neoplasms | 1 | 2017 | 601 | 0.100 |
Why?
|
| Breast Neoplasms | 5 | 2023 | 20774 | 0.100 |
Why?
|
| Receptor, erbB-2 | 1 | 2021 | 2410 | 0.100 |
Why?
|
| Macrophages | 2 | 2023 | 5655 | 0.090 |
Why?
|
| Epigenesis, Genetic | 1 | 2023 | 3639 | 0.090 |
Why?
|
| Lymphatic Metastasis | 1 | 2017 | 2906 | 0.090 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2016 | 1683 | 0.090 |
Why?
|
| Stem Cells | 2 | 2021 | 3563 | 0.080 |
Why?
|
| Neoplasm Metastasis | 1 | 2019 | 4839 | 0.080 |
Why?
|
| Mutation | 4 | 2021 | 29717 | 0.080 |
Why?
|
| Cell Differentiation | 3 | 2023 | 11470 | 0.080 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2018 | 2940 | 0.080 |
Why?
|
| Genetic Loci | 1 | 2017 | 2572 | 0.080 |
Why?
|
| Disease Progression | 3 | 2020 | 13256 | 0.070 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2018 | 3617 | 0.070 |
Why?
|
| Computational Biology | 1 | 2019 | 3518 | 0.070 |
Why?
|
| Neutrophils | 1 | 2019 | 3711 | 0.070 |
Why?
|
| Neoplasm Proteins | 1 | 2019 | 3691 | 0.070 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2021 | 5163 | 0.070 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2016 | 2948 | 0.070 |
Why?
|
| Mice | 6 | 2023 | 81045 | 0.060 |
Why?
|
| Neoplastic Processes | 1 | 2023 | 35 | 0.060 |
Why?
|
| Colonic Neoplasms | 1 | 2016 | 2542 | 0.060 |
Why?
|
| Rats, Inbred ACI | 1 | 2022 | 44 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2023 | 251 | 0.050 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2023 | 261 | 0.050 |
Why?
|
| Animals | 8 | 2023 | 168561 | 0.050 |
Why?
|
| Paracrine Communication | 1 | 2023 | 276 | 0.050 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2017 | 4029 | 0.050 |
Why?
|
| Fibroblasts | 2 | 2023 | 4143 | 0.050 |
Why?
|
| Brain Neoplasms | 1 | 2023 | 8829 | 0.050 |
Why?
|
| Models, Biological | 1 | 2018 | 9581 | 0.050 |
Why?
|
| DNA Copy Number Variations | 2 | 2021 | 1940 | 0.050 |
Why?
|
| Cell Line, Tumor | 4 | 2019 | 16665 | 0.050 |
Why?
|
| Mice, 129 Strain | 1 | 2022 | 386 | 0.050 |
Why?
|
| Methylation | 1 | 2023 | 1107 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2022 | 17400 | 0.050 |
Why?
|
| Myoblasts | 1 | 2021 | 238 | 0.050 |
Why?
|
| Humans | 16 | 2023 | 742088 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2023 | 804 | 0.040 |
Why?
|
| T Cell Transcription Factor 1 | 1 | 2019 | 49 | 0.040 |
Why?
|
| Vesicular Transport Proteins | 1 | 2021 | 377 | 0.040 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2021 | 555 | 0.040 |
Why?
|
| Neoplasm Transplantation | 1 | 2021 | 2085 | 0.040 |
Why?
|
| Oncogenes | 1 | 2023 | 1263 | 0.040 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2017 | 215 | 0.040 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2023 | 2638 | 0.040 |
Why?
|
| Sulfoxides | 1 | 2016 | 48 | 0.040 |
Why?
|
| 3-Hydroxysteroid Dehydrogenases | 1 | 2016 | 34 | 0.040 |
Why?
|
| Lymph Nodes | 2 | 2018 | 3465 | 0.040 |
Why?
|
| Hydroxyprostaglandin Dehydrogenases | 1 | 2016 | 30 | 0.040 |
Why?
|
| Diploidy | 1 | 2016 | 138 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2019 | 2505 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2023 | 2500 | 0.030 |
Why?
|
| Point Mutation | 1 | 2020 | 1624 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2019 | 13019 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2023 | 2524 | 0.030 |
Why?
|
| Biological Evolution | 1 | 2020 | 1074 | 0.030 |
Why?
|
| Female | 7 | 2023 | 379592 | 0.030 |
Why?
|
| Prodrugs | 1 | 2016 | 268 | 0.030 |
Why?
|
| Pedigree | 1 | 2022 | 4646 | 0.030 |
Why?
|
| Gene Dosage | 1 | 2017 | 1251 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 13655 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2016 | 1791 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2022 | 8300 | 0.020 |
Why?
|
| Germ-Line Mutation | 1 | 2019 | 1786 | 0.020 |
Why?
|
| Biological Transport | 1 | 2016 | 2119 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2018 | 8425 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2019 | 1707 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2023 | 4438 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2017 | 3612 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2019 | 2842 | 0.020 |
Why?
|
| Genotype | 1 | 2023 | 12946 | 0.020 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2019 | 1625 | 0.020 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2017 | 1860 | 0.020 |
Why?
|
| Immunotherapy | 1 | 2023 | 4414 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2018 | 2183 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2022 | 14554 | 0.020 |
Why?
|
| Rats | 1 | 2022 | 24265 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2021 | 4933 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2023 | 10163 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2022 | 19223 | 0.020 |
Why?
|
| Proteomics | 1 | 2019 | 3618 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2019 | 11363 | 0.020 |
Why?
|
| Cell Movement | 1 | 2017 | 5212 | 0.020 |
Why?
|
| Software | 1 | 2019 | 4434 | 0.020 |
Why?
|
| Intestinal Mucosa | 1 | 2016 | 3038 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2019 | 5100 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2019 | 10472 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 9410 | 0.010 |
Why?
|
| Middle Aged | 3 | 2021 | 213127 | 0.010 |
Why?
|
| Adult | 3 | 2021 | 213712 | 0.010 |
Why?
|
| Lung | 1 | 2019 | 9826 | 0.010 |
Why?
|
| Aged | 2 | 2023 | 162944 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2019 | 12164 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 2022 | 11039 | 0.010 |
Why?
|
| Time Factors | 1 | 2020 | 40054 | 0.010 |
Why?
|
| Prognosis | 1 | 2018 | 29010 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 57683 | 0.010 |
Why?
|
| Risk Factors | 1 | 2022 | 72145 | 0.010 |
Why?
|
| Male | 2 | 2022 | 349538 | 0.010 |
Why?
|
Concepts
(136)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(34)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_